# EMPAGLIFLOZIN
> **ANDA217055** · Abbreviated New Drug Application (Generic) · Sponsor: AJANTA PHARMA LTD · Approved 2025-04-11
## Drug
- **FDA Application Number:** ANDA217055
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EMPAGLIFLOZIN
- **Generic name:** Empagliflozin
- **Active ingredients:** EMPAGLIFLOZIN
- **Dosage form:** TABLET
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** AJANTA PHARMA LTD
- **First approval:** 2025-04-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217055)
---
*MORVS · CC0 1.0*